Cellbxhealth Plc ADR (OP:ANPCY)
All News about Cellbxhealth Plc ADR
CelLBxHealth PLC Presents Proof-of-Concept Study
November 05, 2025
Cellbxhealth PLC Announces Expert Consensus on CTCs; Update on Funding
November 04, 2025
Angle PLC Announces Strategy Update
October 08, 2025
Angle PLC Announces Presentation of Data on Glioblastoma
September 29, 2025
Angle PLC Announces Board Changes
September 12, 2025
Angle PLC Announces Interim Results
September 09, 2025
Angle PLC Announces Preliminary Results
May 28, 2025
Angle PLC Announces Change of Adviser
September 09, 2025
Angle PLC Announces Notice of Results
September 05, 2025
ANGLE Announces Collaboration with Myriad Genetics
August 20, 2025
Angle PLC Announces Parsortix Used in Research Paper from ETH Zurich
January 24, 2025
Angle PLC Announces Trading Update
January 23, 2025
Angle PLC Announces Board Changes
June 06, 2025
Angle PLC Announces Issue of LTIP Options and Share Options
March 21, 2025
Angle PLC Announces HER2 Presentation at SABCS
December 13, 2024
Angle PLC Announces Research on HER2 Assay Kit Showcased at AACR
November 14, 2024
Angle PLC Announces Parsortix Based PD-L1 Assay Showcased at AACR
November 14, 2024
Angle PLC Announces Results of Eisai Phase 2 pilot study
March 21, 2025
Angle PLC Announces Parsortix enriched CTC & ctDNA in NSCLC patients
November 10, 2024
Angle PLC Announces 100th Publication Supporting Parsortix System Use
September 25, 2024
Angle PLC Announces Half-year Report
September 25, 2024
Angle PLC Announces Exclusive agreement for DNA NGS panel
September 22, 2024
Stock Quote API & Stock News API supplied by www.cloudquote.io
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the Privacy Policy and Terms Of Service.
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the Privacy Policy and Terms Of Service.
© 2025 FinancialContent. All rights reserved.